José Luis López-Campos Bodineau-rekin lankidetzan egindako argitalpenak (21)

2024

  1. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

2023

  1. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  2. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  3. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  4. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 725-735

  5. Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  6. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit

    Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 295-304

2022

  1. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

  2. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO

    ERJ Open Research, Vol. 8, Núm. 3

  3. Determinants in the Underdiagnosis of COPD in Spain—CONOCEPOC Study

    Journal of Clinical Medicine, Vol. 11, Núm. 9

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study

    Archivos de Bronconeumologia

2020

  1. A proposed approach to chronic airway disease (CAD) using therapeutic goals and treatable traits: A look to the future

    International Journal of COPD, Vol. 15, pp. 2091-2100

  2. Knowledge of Chronic Obstructive Pulmonary Disease, Presence of Chronic Respiratory Symptoms and Use of Spirometry Among the Spanish Population: CONOCEPOC 2019 study

    Archivos de Bronconeumologia

  3. The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 17, Núm. 4, pp. 346-354

2019

  1. Assessing the clinical practice in specialized outpatient clinics for chronic obstructive pulmonary disease: Analysis of the EPOCONSUL clinical audit

    PLoS ONE, Vol. 14, Núm. 2

  2. Correction: Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study (PLOS ONE (2018) 13:6 (e0198777) DOI: 10.1371/journal.pone.0198777)

    PLoS ONE

2018

  1. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study

    Archivos de Bronconeumologia, Vol. 54, Núm. 5, pp. 270-279

  2. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study

    PLoS ONE, Vol. 13, Núm. 6

2017

  1. Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: A multi-level, cross-sectional analysis of the EPOCONSUL study

    Respiratory Research, Vol. 18, Núm. 1